John Stewart Sharman - 01 May 2024 Form 4 Insider Report for UNIVERSAL BIOSENSORS INC

Signature
/s/ John Sharman
Issuer symbol
N/A
Transactions as of
01 May 2024
Net transactions value
+$9,458
Form type
4
Filing time
03 May 2024, 06:23:38 UTC
Previous filing
25 Mar 2024
Next filing
28 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBI Common Stock Award $1,500 +10,000 +0.78% $0.1500* 1,286,217 01 May 2024 By wife F1, F2
transaction UBI Common Stock Award $3,458 +23,055 +29% $0.1500* 103,055 01 May 2024 Direct F2
transaction UBI Common Stock Award $4,500 +30,000 +8.2% $0.1500* 394,666 01 May 2024 By superannuation fund F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding UBI Performance Rights 2,500,000 01 May 2024 Common Stock 2,500,000 Direct F4
holding UBI Performance Rights 1,250,000 01 May 2024 Common Stock 1,250,000 Direct F5
holding UBI Stock Option (Right to Buy) 2,364,667 01 May 2024 Common Stock 2,364,667 $0.2500 Direct F2, F6
holding UBI Stock Option (Right to Buy) 1,364,667 01 May 2024 Common Stock 1,364,667 $0.3000 Direct F2, F6
holding UBI Stock Option (Right to Buy) 1,000,000 01 May 2024 Common Stock 1,000,000 $0.3000 By superannuation fund F2, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the shares held by his wife except to the extent of his pecuniary interest therein, and this report should not be deemed an admission that the reporting person is the beneficial owner of his wife's shares for purposes of Section 16 or for any other purpose.
F2 The price reported is stated in Australian dollars.
F3 The reporting person disclaims beneficial ownership of the shares held by his superannuation except to the extent of his pecuniary interest therein, and this report should not be deemed an admission that the reporting person is the beneficial owner of his superannuation funds shares for purposes of Section 16 or for any other purpose.
F4 Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
F5 Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.
F6 These options are fully vested and became exercisable after September 24, 2020.